drugset / Trial / NCT00731393
Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04
RandomizedParallel-groupDouble-blindPrevention
Summary
The aim of the present study is to assess the reactogenicity and immunogenicity of a thiomersal-free influenza vaccine. For comparison, a group of subjects is administered the standard formulation of Influsplit SSW® 2003/2004.
Timeline
- Start
- 2003-10
- Primary completion
- 2004-08
- Completion
- 2004-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Influsplit SSW®/Fluarix™ | Vaccine | — | Intramuscular |
| Subject | Thiomersal free trivalent influenza split vaccine 2003/2004 | Vaccine | — | Intramuscular |